the aid library

LIST OPTIONS

Filter

2779

Download (513)

View PDF (875)

Malawi MDG Endline Survey 2014

National Statistical Office of Malawi; UNICEF; WHO; et al. (2015)

Download (241)

View PDF (311)

World Report on Vision

World Health Organization WHO (2019) C_WHO

At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua... more

Download (211)

View PDF (221)

Tackling antimicrobial use and resistance in pig production: lessons learned in Denmark

Food and Agriculture Organization of the United Nations FAO (2019) C2

This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ... more

Download (190)

View PDF (219)

National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance

Ministry of Health and Medical Education Iran (2016) C_WHO

Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ... more

Download (205)

View PDF (259)

WFP Global Response to COVID-19: September 2020

World Food Programme (2020) CC

The COVID-19 pandemic is a multiplier of vulnerability, compounding threats to food insecurity, while exposing weaknesses in food and health systems. It is severely undermining the capacity of communities to cope in times of crisis and has become a stress test for political and economic stability.

Download (245)

View PDF (215)

Direct and indirect effects of COVID-19 on maternal and child health in Bangladesh

M. M. Ahmmed; M. A. Babu; J. Ferdosy (2021) CC

Bangladesh has been going through incremental trend of GDP growth rates for a long time. The GDP is the key aspect to measure the economic growth of a country. But the current world wide pandemic due to the COVID-19 hardly affects the world’s economy as well as Bangladesh. The present... more

Download (296)

View PDF (277)

Inter-Agency Reproductive Health Kits 6th Edition - Manual

Inter-Agency Working Group on Reproductive Health in Crisis IAWG and UNFPA (2021) C1

Download (1270)

View PDF (1074)

The Haiti Health Sector Directory: U.S.-Based Implementers Working in Haiti

USAID, Synergie Project (2003) C1

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1584)

View PDF (2723)

The Pediatric Clinical Manual

Elaine Abrams, Wafaa El-Sadr, and Miriam Rabkin The International Center for AIDS Programm (2004)

Download (519)

View PDF (825)

Knowledge, Attitudes and Practice surveys Zika virus disease and potential complications. Resource pack

World Health Organization (2016) C_WHO

This is a resource pack for a Knowledge, Attitudes and Practices (KAP) surveys about Zika virus and its suspected complications such as microcephaly and Guillain-Barré syndrome. This resource and associated advice was requested by governments and response partners as a way to rapidly obtain valuab... more

Download (225)

View PDF (206)

WHO technical consultation on oxygen access scale-up for COVID-19

World Health Organization WHO (2021) C_WHO

Download (251)

View PDF (297)

The state of the health workforce in the WHO African Region, 2021

WHO Universal Health CoverageLife Course Cluster, WHO Regional Office for Africa (2021) C_WHO

Download (608)

View PDF (998)

Malawi MDG Endline Survey 2014. Key Findings

National Statistical Office of Malawi; UNICEF; WHO; et al. (2016)

Download (285)

View PDF (318)

Comparative Study of Pharmaceutical Waste Disposal in Ethiopia, Kenya, Sudan and Uganda

Iosue, S. PSA Tansforming The Supply Chain (2020) C1

Download (195)

View PDF (244)

Global competency and outcomes framework for universal health coverage

World Health Organization WHO (2022) C_WHO

Download (165)

View PDF (193)

National Family Health Survey (NFHS-5), India, 2019-21: Jharkhand

International Institute for Population Sciences (IIPS) and ICF Ministry of Health and Family Welfare (2021) CC

August 2021 This report presents the key findings of the NFHS-5 survey in Jharkhand, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India ... more

Download (471)

View PDF (891)

A wake-up call El Niño’s impact on children. Briefing Note.

UNICEF (2015) C1

Download (252)

View PDF (240)

Liberia: How reinforced community health structures and capitalizing on lessons learned from the Ebola virus epidemic of 2014–16 helped the country respond to the challenge of its second major disease

World Health Organization WHO (2021) C_WHO

Download (516)

View PDF (1094)

National HIV & AIDS Strategic Plan 2016-2020

Ministry of Health, Ghana; Ghana AIDS Commission (2016) C1